ABPI
Pharma to disclose doctor payments
July 4, 2013Medical Communications, Research and Development, Sales and Marketing ABPI, EFPIA, pharma, transparency
Pharma companies in Europe will have to reveal how much they pay to doctors under a voluntary agreement set out …
Merck Serono censured over calls
June 25, 2013Medical Communications, Sales and Marketing ABPI, Erbitux, Merck Serono, PMCPA
A Merck Serono medical representative has been accused of ‘harassing’ an anonymous health professional by requesting a meeting every month …
New ABPI director of communications announced
June 17, 2013Medical Communications, Research and Development, Sales and Marketing ABPI, Meadden, Whitehead
The ABPI has appointed its head of Policy and Public Affairs Catherine Meaden to be the organisation’s new director of …
Leo exaggerates Picato properties
June 14, 2013Medical Communications, Sales and Marketing ABPI, LEO Pharma, PMCPA
Leo Pharma has been censured by the PMCPA for not maintaining high standards over an advertisement that overreached itself when …
ABPI: put more data in scorecards
June 12, 2013Sales and Marketing ABPI, NHS, scorecards
The ABPI has called on the NHS to include more new medicines in its innovation scorecard and to come up …
ABPI declares eye health services ‘unsustainable’
June 11, 2013Sales and Marketing ABPI, NHS England, POPI, eye health
The ABPI’s Pharmaceutical Ophthalmology Initiative (POPI) group has called for a major re-think in how eye services are delivered on the NHS.The …
Bad pharma, good pharma: an insider’s view
May 30, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Bad pharma, Goldacre, NICE, transparancy
Most people in the pharmaceutical industry, particularly in the UK, will be well-acquainted with Ben Goldacre by now. He published his …
ABPI takes on vaccine industry brief
May 22, 2013Research and Development ABPI, vaccines
The ABPI is to take on responsibility for representing the vaccine industry to UK government and healthcare stakeholders.For more than …
Pfizer targets Newcastle
May 15, 2013Research and Development, Sales and Marketing ABPI, Cameron, NHS, Newcastle, Pfizer
Pfizer has earmarked Newcastle Hospitals NHS Foundation Trust as one of 60 sites worldwide to take part in a key …
VBP will be ‘unfair’: report
May 8, 2013Medical Communications, Research and Development, Sales and Marketing 2020health, ABPI, NHS, VBP
A new report on value-based pricing (VBP) concludes that the new system will be unfair to patients and says the …
Boehringer’s online PMCPA breach
April 25, 2013Medical Communications, Research and Development, Sales and Marketing ABPI, AF, Boehringer, PMCPA
Boehringer Ingelheim has failed to uphold high standards, according to the PMCPA, which enforces the ABPI Code of Practice, over …
‘No consensus’ on transparency
April 22, 2013Medical Communications, Research and Development, Sales and Marketing ABPI, Goldacre, Whitehead, all trials, transparency
An ABPI meeting on increasing the transparency of the way clinical trials are reported has thrown up more questions than …
OHE: drugs spend to rise
April 16, 2013Medical Communications, Sales and Marketing ABPI, OHE
UK medicines expenditure is set to grow between 3.1% and 4.1% by 2015, according to a study which the researchers …
Pharma pays doctors £40m
April 9, 2013Sales and Marketing ABPI, Bad pharma, ethics
Health professionals received £40 million in payments from pharma companies last year, according to new figures released by the ABPI.This …
Ten pharma firms censured
March 28, 2013Medical Communications, Sales and Marketing ABPI, PMCPA
Ten pharma companies have been found guilty by the PMCPA of failing to maintain high standards over their involvement in …
Latest content
FibroFind appoints Lee Borthwick as CEO
